3-D research model tackles prostate cancer spread

April 24, 2009

Shirly Sieh, a PhD student at IHBI, is studying the way cancer cells escape from the prostate through the bloodstream to form tumour colonies, most often in the spine and long bones.

"It is an innovative study which uses a tissue engineering platform technology developed by IHBI's Professor Dietmar W. Hutmacher in order to investigate the interaction between bones and cancer cells," Ms Sieh said.

"Tissue-engineered bone provides the 3D architecture for the cancer cells which more closely resemble bone metastasis instead of growing the cancer cells and bone cells on a flat Petrie dish.

"I am growing prostate cancer cells on the tissue-engineered bone to observe the interactions between the cells and the surrounding tissue so it is a way of mimicking the cancer cells invading the bone environment."

Ms Sieh said it was still not clear to researchers how bones and cancer cells interacted.

"With this 3D method we can see if and how the cancer cells 'set up home' in the bone cells," she said.

"We want to study how the cancer cells degrade the matrix, or the mix of proteins and growth factors produced by these cells, and remodel the environment to suit the cancer cells to grow a tumour."

Ms Sieh said scientists also wanted to understand why prostate cancer cells were attracted to the bone sites. She and Amy Lubik, a PhD student supervised by Professor Colleen Nelson, are studying the effect the cancer cells in the bone have on male hormone production, particularly on the hormone, androgen.

"People with advanced cancer who have had prostate removal surgery should have low levels of androgen and the cancer cells should be suppressed. However, sometimes the cancer cells do recur," she said.

"We think it might have something to do with the fact that the cancer cells are very sensitive to androgen and even low levels of androgen in the body could promote the growth of these cancer cells."

Ms Sieh said previous research had found that when the prostate cancer cells changed the bone environment they eventually induced more bone formation.

"But it is very abnormal growth which can cause bone fractures and painful spinal compression for the person. "
-end-
Ms Sieh's research is supervised by an interdisciplinary team made up of Professors Hutmacher, Judith Clements and Colleen Nelson, director of the federally-funded Australian Prostate Cancer Research Centre - Queensland located at Princess Alexandra Hospital campus and hosted by QUT.

Queensland University of Technology

Related Cancer Cells Articles from Brightsurf:

Cancer researchers train white blood cells to attacks tumor cells
Scientists at the National Center for Tumor Diseases Dresden (NCT/UCC) and Dresden University Medicine, together with an international team of researchers, were able to demonstrate that certain white blood cells, so-called neutrophil granulocytes, can potentially - after completing a special training program -- be utilized for the treatment of tumors.

New way to target some rapidly dividing cancer cells, leaving healthy cells unharmed
Scientists at Johns Hopkins Medicine and the University of Oxford say they have found a new way to kill some multiplying human breast cancer cells by selectively attacking the core of their cell division machinery.

Breast cancer cells use message-carrying vesicles to send oncogenic stimuli to normal cells
According to a Wistar study, breast cancer cells starved for oxygen send out messages that induce oncogenic changes in surrounding normal epithelial cells.

Breast cancer cells turn killer immune cells into allies
Researchers at Johns Hopkins University School of Medicine have discovered that breast cancer cells can alter the function of immune cells known as Natural killer (NK) cells so that instead of killing the cancer cells, they facilitate their spread to other parts of the body.

Breast cancer cells can reprogram immune cells to assist in metastasis
Johns Hopkins Kimmel Cancer Center investigators report they have uncovered a new mechanism by which invasive breast cancer cells evade the immune system to metastasize, or spread, to other areas of the body.

Engineered immune cells recognize, attack human and mouse solid-tumor cancer cells
CAR-T therapy has been used successfully in patients with blood cancers such as lymphoma and leukemia.

Drug that keeps surface receptors on cancer cells makes them more visible to immune cells
A drug that is already clinically available for the treatment of nausea and psychosis, called prochlorperazine (PCZ), inhibits the internalization of receptors on the surface of tumor cells, thereby increasing the ability of anticancer antibodies to bind to the receptors and mount more effective immune responses.

Engineered bone marrow cells slow growth of prostate and pancreatic cancer cells
In experiments with mice, researchers at the Johns Hopkins Kimmel Cancer Center say they have slowed the growth of transplanted human prostate and pancreatic cancer cells by introducing bone marrow cells with a specific gene deletion to induce a novel immune response.

First phase i clinical trial of CRISPR-edited cells for cancer shows cells safe and durable
Following the first US test of CRISPR gene editing in patients with advanced cancer, researchers report these patients experienced no negative side effects and that the engineered T cells persisted in their bodies -- for months.

Zika virus' key into brain cells ID'd, leveraged to block infection and kill cancer cells
Two different UC San Diego research teams identified the same molecule -- αvβ5 integrin -- as Zika virus' key to brain cell entry.

Read More: Cancer Cells News and Cancer Cells Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.